< Back to latest news & events

Brexit

No Official Fee Will Be Payable On Automatic Conversion Of Registered EU Trade Marks And Designs

July 2020

UK Government confirms no official Registry fee will be payable on automatic conversion of registered EU trade marks and designs into national UK rights post-Brexit.

The United Kingdom Government confirmed on 19th July 2018 that, it will convert all existing registered European Union trade mark and design registrations automatically and crucially for free into national UK registrations following the UK’s exit from the EU, the so-called Brexit.

Robin Walker MP, the Parliamentary Under-Secretary of State for Exiting the European Union, made the commitment during a debate in the House of Commons. He said: “We have agreed to protect all existing EU trade marks, community registered designs and unregistered designs in the UK as we leave the EU. In place of those EU-level rights, 1.5 million new UK trade marks and registered designs will be granted automatically and for free”.

The UKIPO subsequently confirmed this to be the case subject to the finalisation of a Withdrawal Agreement (between the UK and EU relating to the UK’s departure from the EU and the UK/EU’s future relationship). This announcement follows on from an existing draft agreement between the UK and the EU Commission, providing that EU trade marks and registered designs should continue to be protected automatically in the UK. In addition, subject to an overall deal on a transitional period going ahead, the UK will continue to be part of the EU trade mark and design system until the end of December 2020.

This is great news for IP owners. Provided the UK Government keeps to this commitment, there should be no need to refile existing EU trade marks and designs in the UK. The news that the process will be free is particularly welcome. However, given ongoing political uncertainty as the final terms of a Withdrawal Agreement and, indeed whether one will be reached at all, and the precise processes to be adopted relating to the “cloning” of EU mark onto the UK Trade Marks Register, we will continue to scrutinise very closely the developing legal position.

If you would like any further information regarding the above or have any specific queries on how this might impact on your trade mark rights, please speak to a member of the Trade Marks team or your usual HGF contact.

Latest updates

HGF Ranked #1 in the UK for Trade Mark Portfolios in the 2025 Trade Mark Filing Trends Report by Clarivate.

HGF has achieved the #1 ranking for the UK for trade mark portfolios in the newly released 2025 Trade mark Filing Trends report by Clarivate, recognising the firm as a …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The Enlarged Board of Appeal has today issued its decision in seminal case G1/24.

G1/24, described as one of the most important cases in decades, relates to how claims of patents are to be interpreted by the Boards of Appeal and, by extension, all …

Read article

UPC’s Hamburg Local Division provides guidance on the extent to which a patent may be used as its own “lexicon”

Agfa NV v Gucci & Anors. [UPC_CFI_278/2023] – Hamburg Local Division of the UPC (Klepsch, Schilling, Sarlin) – 30 April 2025 While we await a decision on G1/24 from the …

Read article

MevoCem Nominated for the Earthshot Prize by CIPA

We’re delighted to share that our client, Material Evolution, has been nominated by the Chartered Institute of Patent Attorneys (CIPA) for the globally renowned Earthshot Prize, in recognition of their …

Read article

Agritech Thymes: Agritech 2030: Forecasting the Technologies Poised to Transform Farming

Whilst yet to recover to the levels of 2011-2021, where capital invested in agritech increased 20-fold, investor funding in agritech is starting to pick up, and 2025 is set to …

Read article

UPC delivers first judgment on Validity and Infringement of a Second Medical Use Claim

Sanofi Biotechnology SAS & Anor v Amgen, Inc., & Ors– Thomas, Thom, Kupecz and Dorland-Galliot – [UPC_CFI_505/2024] The Dusseldorf Local Division (LD) has delivered the UPC’s first Judgment on second …

Read article